SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (541)12/20/2004 10:47:09 PM
From: rkrw  Read Replies (2) of 625
 
I read a recent broker report that pegged net royalty to catg going from 0.7% to 2.1% post this win. May be a shade higher as the judge noted full royalties of just over 5%.

Market cap needs to be adjusted up for the recent azn equity purchase.

Royalty not close to getting catg to b/e and not much internal pipeline exposure. Market cap >$700M I believe. I sold today. Very pleased with how it turned out.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News